Type I interferon signaling promotes early innate control of Borrelia burgdorferi infection
PLOS Pathogens · 26.10.2026 · 22 (10) · e1013996
DOI: 10.1371/journal.ppat.1013996 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 26.10.2026. Verfasst von Raj Priya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America. Hauptthemen laut MEDLINE: Lyme Disease, Interferon Type I, Borrelia burgdorferi, Signal Transduction. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, USA.
Abstract (Originalsprache)
Borrelia burgdorferi , the causative agent of Lyme disease, elicits a robust type I interferon (IFN-I) response that has been strongly associated with chronic inflammatory manifestations such as Lyme arthritis. Although IFN-I is known to be induced early during infection, its functional role in the initial stages of B. burgdorferi infection remains unclear. Here, we identify a protective role for IFN-I signaling in the early control of B. burgdorferi . At 5 days post-challenge, mice lacking the type I interferon receptor (IFNAR1) exhibited markedly elevated spirochetal burdens at the site of inoculation, indicating that IFN-I signaling contributes to restricting early bacterial expansion. By 10 days post-challenge, IFNAR1 deficiency resulted in significantly increased bacterial loads in the skin and a trend toward higher loads in heart tissues, while joint burdens remained unaffected. Mechanistically, IFN-I signaling enhanced macrophage uptake of B. burgdorferi , phagosomal processing, and intracellular killing, while also modulating inflammatory cytokine responses and promoting macrophage recruitment to the inoculation site. Conversely, pharmacological activation of IFN-I signaling augmented macrophage antimicrobial function and improved bacterial clearance. Together, these findings establish IFN-I as a key component of early host defense against B. burgdorferi and reveal a time-dependent role for IFN-I signaling in Lyme disease pathogenesis, with protective functions during early infection that contrast with its pathogenic effects at later stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
- Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
ORCID-Profile: X Frank Yang
Förderung
- NIAID NIH HHS
- National Institutes of Health, USA
Zitieren
APA
Priya, R., Raghunandanan, S., Mihaljica, D., Alakhras, N. S., Kaplan, M. H., & Yang, X. F. (2026). Type I interferon signaling promotes early innate control of Borrelia burgdorferi infection. PLOS Pathogens, 22(10), e1013996. https://doi.org/10.1371/journal.ppat.1013996
Vancouver
Priya R, Raghunandanan S, Mihaljica D, Alakhras NS, Kaplan MH, Yang XF. Type I interferon signaling promotes early innate control of Borrelia burgdorferi infection. PLOS Pathogens. 2026;22(10):e1013996. doi:10.1371/journal.ppat.1013996
BibTeX
@article{Priya2026,
author = {Priya, Raj and Raghunandanan, Sajith and Mihaljica, Darko and Alakhras, Nada S and Kaplan, Mark H and Yang, X Frank},
title = {Type I interferon signaling promotes early innate control of Borrelia burgdorferi infection},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {10},
pages = {e1013996},
doi = {10.1371/journal.ppat.1013996}
}
EUVIMED